Haemonetics | HAE - Sales Revenues


Haemonetics reported $339M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Cerus USD 50.81M 4.79M Dec/2024
Cooper Companies USD 1.08B 57.4M Mar/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
ICU Medical USD 525.77M 14.93M Mar/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Neogen USD 225.3M 14.1M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Quidel USD 620M 104M Mar/2026
ResMed USD 1.46B 60M Jun/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 300.32B 3.69B Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
US Physical Therapy USD 214.1M 15.8M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026